デフォルト表紙
市場調査レポート
商品コード
1769759

禁煙製品の世界市場レポート2025年

Smoking Cessation Products Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
禁煙製品の世界市場レポート2025年
出版日: 2025年07月07日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

禁煙製品の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率(CAGR)は8.1%で、329億8,000万米ドルに成長します。このような成長が見込まれる背景には、禁煙を試みる個人の増加、歴史的に喫煙率の高い高齢化、禁煙プログラムを支援する有利な規制枠組み、たばこ関連がん患者の急増、より厳格なたばこ規制対策と課税政策の実施などがあります。予測期間における主な動向としては、製品提供の多様化、ニコチン置換療法の継続的使用、禁煙ソリューションへのアクセスの容易化、行動療法と薬理学的補助手段の統合、ニコチン送達方法の技術進歩などが挙げられます。

喫煙関連疾患の有病率の増加は、今後数年間の禁煙製品市場の成長を促進すると予想されます。タバコの使用が直接的または間接的にもたらすこれらの病気は、体内のさまざまな臓器やシステムに影響を及ぼします。タバコの継続的な使用は有害な化学物質への暴露を長引かせ、長期的なダメージと慢性疾患のリスク上昇につながります。こうした疾病の発生率が上昇するにつれ、健康意識の高まりと医学的診断が、より多くの個人に効果的な禁煙方法を求めるよう促し、禁煙補助製品の需要を高めています。例えば、2025年1月に米国がん協会が発表したところによると、米国では2025年に約22万6650人の肺がん患者が新たに発生すると予測されており、その内訳は男性が11万0680人、女性が11万5970人となっています。肺がん関連死は約124,730人に達すると予想され、その内訳は男性64,190人、女性60,540人です。このように喫煙に関連する疾病の負担が増加していることは、禁煙製品の市場が拡大していることを裏付けています。

禁煙製品市場で事業を展開する企業は、回復の成果を向上させ、再発を予防するために、認知度を高め、地域社会の支援を促進する脱中毒キャンペーンを開始することを重視しています。これらのキャンペーンは、薬物依存に悩む個人を支援し、より健康的なライフスタイルの選択を促進することを目的としています。例えば、2023年4月、インドを拠点とする製薬会社Rusan Pharmaは、24時間ニコチン経皮パッチを提供する自社ブランド2baconilを通じて、脱タバコキャンペーンを導入しました。NoReasonIsGoodEnough」と題されたこのキャンペーンは、個人が喫煙習慣を様々な理由で正当化することが多いという考えに基づいて構築されました。2baconilのニコチンパッチがいかにニコチンへの身体的・心理的依存を減らすのに役立つかを強調しています。同ブランドの製品には、禁煙を支援するニコチンパッチとガムの両方があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の禁煙製品:PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の禁煙製品市場:成長率分析
  • 世界の禁煙製品市場の実績:規模と成長, 2019-2024
  • 世界の禁煙製品市場の予測:規模と成長, 2024-2029, 2034F
  • 世界の禁煙製品:総潜在市場規模(TAM)

第6章 市場セグメンテーション

  • 世界の禁煙製品市場:製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • ニコチン置換療法
  • 処方薬
  • OTC薬
  • 電子タバコ
  • 世界の禁煙製品市場:処方タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 歯茎
  • ロゼンジ
  • パッチ
  • 吸入器
  • 鼻スプレー
  • 世界の禁煙製品市場:流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 薬局
  • オンライン小売
  • スーパーマーケット
  • 医療提供者
  • 世界の禁煙製品市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 大人
  • ティーンエイジャー
  • 妊婦
  • 世界の禁煙製品市場、ニコチン置換療法、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • ガム
  • パッチ
  • ロゼンジ
  • 吸入器
  • 鼻スプレー
  • 世界の禁煙製品市場、処方薬、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • バレニクリン
  • ブプロピオン
  • ノルトリプチリン
  • クロニジン
  • 世界の禁煙製品市場、OTC薬、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • ニコチンガム
  • ニコチンロゼンジ
  • ハーブロゼンジ
  • ニコチンを含まない錠剤
  • 世界の禁煙製品市場、電子タバコ、タイプ別サブセグメンテーション:実績と予測, 2019-2024, 2024-2029F, 2034F
  • 使い捨て電子タバコ
  • 充電式電子タバコ
  • モジュラー電子タバコ
  • ポッド型電子タバコ

第7章 地域別・国別分析

  • 世界の禁煙製品市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の禁煙製品市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 禁煙製品市場:競合情勢
  • 禁煙製品市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • Imperial Brands PLC Overview, Products and Services, Strategy and Financial Analysis
    • GlaxoSmithKline(GSK)Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • British American Tobacco PLC
  • Philip Morris International Inc.
  • Haleon Group of Companies
  • Perrigo Company
  • Dr. Reddy's Laboratories
  • Cipla Ltd.
  • Fertin Pharma
  • Lucy
  • Euro-Pharm International Canada Inc.
  • Alkalon A/S
  • Enorama Pharma AB
  • Niconovum AB
  • Sparsha Pharma International Pvt Ltd
  • The Harvard Drug Group
  • Revolymer

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 禁煙製品市場2029:新たな機会を提供する国
  • 禁煙製品市場2029:新たな機会を提供するセグメント
  • 禁煙製品市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r36076

Smoking cessation products are therapeutic solutions developed to support individuals in reducing or completely stopping their tobacco use by addressing both the physical and psychological dependencies associated with nicotine addiction. These aids operate by either progressively decreasing nicotine levels in the body or offering alternatives that help manage cravings and withdrawal symptoms.

The primary categories of smoking cessation products include nicotine replacement therapy (NRT), prescription medications, over-the-counter remedies, and electronic cigarettes. NRT is a clinically approved method that delivers controlled amounts of nicotine to ease withdrawal symptoms and support smoking cessation efforts. It comes in various forms such as patches, gums, lozenges, nasal sprays, and inhalers, and is available through pharmacies, online platforms, supermarkets, and medical professionals. These products cater to a wide range of users, including adults, adolescents, and expectant mothers.

The smoking cessation products market research report is one of a series of new reports from The Business Research Company that provides smoking cessation products market statistics, including smoking cessation products industry global market size, regional shares, competitors with a smoking cessation products market share, detailed smoking cessation products market segments, market trends and opportunities, and any further data you may need to thrive in the smoking cessation products industry. This smoking cessation products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smoking cessation products market size has grown strongly in recent years. It will grow from $22.25 billion in 2024 to $24.13 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. This historical growth can be credited to heightened awareness regarding the health dangers of smoking, an increase in smoking-related respiratory conditions, extensive government and public health initiatives encouraging smoking cessation, wider adoption of nicotine replacement solutions, and increased spending on healthcare due to smoking-related diseases.

The smoking cessation products market size is expected to see strong growth in the next few years. It will grow to $32.98 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. This anticipated growth will be driven by a rising number of individuals trying to quit smoking, the aging population with historically high smoking rates, favorable regulatory frameworks supporting cessation programs, a surge in tobacco-related cancer cases, and the implementation of more rigorous tobacco control measures and taxation policies. Key trends in the forecast period include diversification of product offerings, continued use of nicotine replacement therapies, improved ease of access to cessation solutions, integration of behavioral therapies with pharmacological aids, and advancements in technology for nicotine delivery methods.

The increasing prevalence of smoking-related diseases is expected to drive the growth of the smoking cessation products market in the coming years. These diseases, which result directly or indirectly from tobacco use, impact various organs and systems within the body. The continued use of tobacco prolongs exposure to harmful chemicals, leading to long-term damage and an elevated risk of chronic conditions. As the incidence of these diseases rises, growing health awareness and medical diagnoses are encouraging more individuals to seek effective ways to quit smoking, thereby increasing demand for cessation products. For example, in January 2025, the American Cancer Society reported that the United States is projected to see approximately 226,650 new lung cancer cases in 2025, with 110,680 in males and 115,970 in females. Lung cancer-related deaths are expected to reach around 124,730, including 64,190 men and 60,540 women. This increasing burden of smoking-related illnesses underscores the growing market for smoking cessation products.

Companies operating in the smoking cessation products market are emphasizing the launch of de-addiction campaigns to raise awareness and foster community support that improves recovery outcomes and helps prevent relapse. These campaigns aim to support individuals struggling with substance dependence and promote healthier lifestyle choices. For instance, in April 2023, Rusan Pharma, an India-based pharmaceutical company, introduced a tobacco de-addiction campaign through its brand 2baconil, which offers a 24-hour nicotine transdermal patch. The campaign, titled #NoReasonIsGoodEnough, was built around the idea that individuals often justify their smoking habits with various reasons. It highlights how 2baconil's nicotine patches can help reduce both the physical and psychological reliance on nicotine. The brand's product offerings include both nicotine patches and gum to aid individuals in quitting smoking.

In April 2024, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical firm, acquired the global Nicotine Replacement Therapy (NRT) business of Haleon Plc for $619 million. This acquisition brought into Dr. Reddy's portfolio Nicotinell, a leading global brand in nicotine replacement therapy with a presence in more than 30 countries across Europe, Asia, and Latin America. It also included other notable regional brands such as Nicabate, Thrive, and Habitrol. The product range includes lozenges, patches, gums, and other upcoming products, serving major international markets, excluding the United States. Haleon Plc is a UK-based company that manufactures smoking cessation products.

Major players in the smoking cessation products market are Pfizer Inc., Johnson & Johnson, Novartis AG, Imperial Brands PLC, GlaxoSmithKline (GSK), British American Tobacco PLC, Philip Morris International Inc., Haleon Group of Companies, Perrigo Company, Dr. Reddy's Laboratories, Cipla Ltd., Fertin Pharma, Lucy, Euro-Pharm International Canada Inc., Alkalon A/S, Enorama Pharma AB, Niconovum AB, Sparsha Pharma International Pvt Ltd, The Harvard Drug Group, and Revolymer.

North America was the largest region in the smoking cessation products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in smoking cessation products report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the smoking cessation products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The smoking cessation products market consists of sales of non-nicotine prescription medications, quit smoking supplements, and detox and recovery aids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Smoking Cessation Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on smoking cessation products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for smoking cessation products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The smoking cessation products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Nicotine Replacement Therapy; Prescription Drugs; Over-The-Counter Drugs; Electronic Cigarettes
  • 2) By Formulation Type: Gums; Lozenges; Patches; Inhalers; Nasal Sprays
  • 3) By Distribution Channel: Pharmacies; Online Retail; Supermarkets; Health Care Providers
  • 4) By End-User: Adults; Teenagers; Pregnant Women
  • Subsegments:
  • 1) By Nicotine Replacement Therapy: Gum; Patch; Lozenge; Inhaler; Nasal Spray
  • 2) By Prescription Drugs: Varenicline; Bupropion; Nortriptyline; Clonidine
  • 3) By Over-The-Counter Drugs: Nicotine Gum; Nicotine Lozenges; Herbal Lozenges; Non-nicotine Tablets
  • 4) By Electronic Cigarettes: Disposable E-cigarettes; Rechargeable E-cigarettes; Modular E-cigarettes; Pod-Based E-cigarettes
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Novartis AG; Imperial Brands PLC; GlaxoSmithKline (GSK)
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Smoking Cessation Products Market Characteristics

3. Smoking Cessation Products Market Trends And Strategies

4. Smoking Cessation Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Smoking Cessation Products Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Smoking Cessation Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Smoking Cessation Products Market Growth Rate Analysis
  • 5.4. Global Smoking Cessation Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Smoking Cessation Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Smoking Cessation Products Total Addressable Market (TAM)

6. Smoking Cessation Products Market Segmentation

  • 6.1. Global Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nicotine Replacement Therapy
  • Prescription Drugs
  • Over-The-Counter Drugs
  • Electronic Cigarettes
  • 6.2. Global Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gums
  • Lozenges
  • Patches
  • Inhalers
  • Nasal Sprays
  • 6.3. Global Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pharmacies
  • Online Retail
  • Supermarkets
  • Health Care Providers
  • 6.4. Global Smoking Cessation Products Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Teenagers
  • Pregnant Women
  • 6.5. Global Smoking Cessation Products Market, Sub-Segmentation Of Nicotine Replacement Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gum
  • Patch
  • Lozenge
  • Inhaler
  • Nasal Spray
  • 6.6. Global Smoking Cessation Products Market, Sub-Segmentation Of Prescription Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Varenicline
  • Bupropion
  • Nortriptyline
  • Clonidine
  • 6.7. Global Smoking Cessation Products Market, Sub-Segmentation Of Over-The-Counter Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Nicotine Gum
  • Nicotine Lozenges
  • Herbal Lozenges
  • Non-nicotine Tablets
  • 6.8. Global Smoking Cessation Products Market, Sub-Segmentation Of Electronic Cigarettes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable E-cigarettes
  • Rechargeable E-cigarettes
  • Modular E-cigarettes
  • Pod-Based E-cigarettes

7. Smoking Cessation Products Market Regional And Country Analysis

  • 7.1. Global Smoking Cessation Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Smoking Cessation Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Smoking Cessation Products Market

  • 8.1. Asia-Pacific Smoking Cessation Products Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Smoking Cessation Products Market

  • 9.1. China Smoking Cessation Products Market Overview
  • 9.2. China Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Smoking Cessation Products Market

  • 10.1. India Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Smoking Cessation Products Market

  • 11.1. Japan Smoking Cessation Products Market Overview
  • 11.2. Japan Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Smoking Cessation Products Market

  • 12.1. Australia Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Smoking Cessation Products Market

  • 13.1. Indonesia Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Smoking Cessation Products Market

  • 14.1. South Korea Smoking Cessation Products Market Overview
  • 14.2. South Korea Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Smoking Cessation Products Market

  • 15.1. Western Europe Smoking Cessation Products Market Overview
  • 15.2. Western Europe Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Smoking Cessation Products Market

  • 16.1. UK Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Smoking Cessation Products Market

  • 17.1. Germany Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Smoking Cessation Products Market

  • 18.1. France Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Smoking Cessation Products Market

  • 19.1. Italy Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Smoking Cessation Products Market

  • 20.1. Spain Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Smoking Cessation Products Market

  • 21.1. Eastern Europe Smoking Cessation Products Market Overview
  • 21.2. Eastern Europe Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Smoking Cessation Products Market

  • 22.1. Russia Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Smoking Cessation Products Market

  • 23.1. North America Smoking Cessation Products Market Overview
  • 23.2. North America Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Smoking Cessation Products Market

  • 24.1. USA Smoking Cessation Products Market Overview
  • 24.2. USA Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Smoking Cessation Products Market

  • 25.1. Canada Smoking Cessation Products Market Overview
  • 25.2. Canada Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Smoking Cessation Products Market

  • 26.1. South America Smoking Cessation Products Market Overview
  • 26.2. South America Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Smoking Cessation Products Market

  • 27.1. Brazil Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Smoking Cessation Products Market

  • 28.1. Middle East Smoking Cessation Products Market Overview
  • 28.2. Middle East Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Smoking Cessation Products Market

  • 29.1. Africa Smoking Cessation Products Market Overview
  • 29.2. Africa Smoking Cessation Products Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Smoking Cessation Products Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Smoking Cessation Products Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Smoking Cessation Products Market Competitive Landscape And Company Profiles

  • 30.1. Smoking Cessation Products Market Competitive Landscape
  • 30.2. Smoking Cessation Products Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Imperial Brands PLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. GlaxoSmithKline (GSK) Overview, Products and Services, Strategy and Financial Analysis

31. Smoking Cessation Products Market Other Major And Innovative Companies

  • 31.1. British American Tobacco PLC
  • 31.2. Philip Morris International Inc.
  • 31.3. Haleon Group of Companies
  • 31.4. Perrigo Company
  • 31.5. Dr. Reddy's Laboratories
  • 31.6. Cipla Ltd.
  • 31.7. Fertin Pharma
  • 31.8. Lucy
  • 31.9. Euro-Pharm International Canada Inc.
  • 31.10. Alkalon A/S
  • 31.11. Enorama Pharma AB
  • 31.12. Niconovum AB
  • 31.13. Sparsha Pharma International Pvt Ltd
  • 31.14. The Harvard Drug Group
  • 31.15. Revolymer

32. Global Smoking Cessation Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Smoking Cessation Products Market

34. Recent Developments In The Smoking Cessation Products Market

35. Smoking Cessation Products Market High Potential Countries, Segments and Strategies

  • 35.1 Smoking Cessation Products Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Smoking Cessation Products Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Smoking Cessation Products Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer